Methods: Action research study phase 1 by retrospective study from medical record in one community hospital during October 2014 to September 2015. Situation of asthma exacerbation was survey from patients with recurrent asthma exacerbation at least 2 times per year and in-depth interview healthcare providers, patient and caregivers.
1 1
Poh-Ai hospital, Taiwan
Background and Aims: Bitter taste is sensed by type 2 taste receptors (TAS2Rs) which evoke G-protein cascade to release intracellular calcium and to activate transient receptor potential M5 (TRPM5) then stimulate vagal sensory fibre to complete communication with the brain. Two TAS2R agonists (chloroquine, quinine) inhibited mitogen-induced ASM growth for about 60% to 70% (P. Sharma 2016, LoE:[5] )(level of evidence). Airway smooth muscle (ASM) relaxed by TAS2R agonists was observed under cryopreserved human precision-cut lung slices (hPCLSs) as a robust bioassay (Bai Y. 2016, LoE:[5] ).
Methods: An EBM-based survey in Pubmed by searching keywords "bitter taste receptor", "asthma", "airway smooth muscle", limited in English language and human study, published date between 2016/Jan/1 to 2018/Apr/30 was done. EBM level is followed the Oxford centre for EBM 2011 edition.
Results: HEK-293T cell surface TAS2R14 expression increased by $5-fold when β2-adrenergic receptors were co-expressed and, with a prolonged β-agonist exposure, TAS2R14 internalized (Kim D. 2016, LoE:[5] . Using Phosphoinositide-specific phospholipase C (PLC) inhibitor, researchers found calcium mobilized through the Quinine-T2R-Gαβγ-PLC pathway (Jaggupilli A. 2017, LoE:[5] ). Most highly expressed ASM TAS2R10 and TAS2R14 subtypes were studied to find 15 and 23 single nucleotide polymorphisms (SNPs) for each other. A positive bronchodilator response (BDR) on -1897T>C (OR = 3.05, 95%CI 1.01-9.23, Pvalue = 0.04) and a low mean asthma control test (ACT) score on -815T>C (OR = 5.84, 95%CI = 1.94-17.61 P = 0.001) were associated in the TAS2R14 gene (S.Y. Yoon 2016, LoE:[3] ). In ASM cells, TAS2R agonists decreased mitochondrial membrane potential and increased ROS and fragmentation. Inhibiting dynamin-like protein 1 (DLP1) reversed TAS2R agonist-induced mitochondrial membrane potential change and attenuated fragmentation and cell death (Pan S. 2017, LoE:[5] ). Beta2AR increased surface expression of TAS2R14 but, by direct receptor-receptor desensitization of TAS2R14 function, prolong β-agonist activation offset TAS2R expression. 3:93-94, doi: 10.1111/resp.13207_20). It is diagnosed when the FEV 1 falls more than 10% after a test with isocapnic hyperventilation of cold air through the mouth. We aimed to assess the influence of cold air on the nasal resistance in asthmatics with CAH at the acute nasal provocation with cold air.
Methods:
In 18 subjects with mild asthma (mean age 38. AE .3 years; FEV 1 = 96. AE .5% of predicted) with CAH (the drop of FEV 1 after 3-min isocapnic hyperventilation through the mouth with cold (−20 C) air was on average -16. AE .9%) the nasal breathing was assessed at frontal rhinomanometry and FEV 1 change was measured by spirometry before and after nasal test with 3-minute isocapnic hyperventilation with cold air.
Results: Initially all the subjects had a higher nasal resistance to the airflow under the pressure 150 Pa (R150): on average in the group on the right-hand side (Rr) it was 0.8 AE .13, and on the left-hand side (Rl) it was 0.6 AE .13 Pa/(mL/s). After 3-minute isocapnic hyperventilation with cold air through the nose the nasal resistance grew: Rr till 1.5 AE .28 Pa/(mL/s) (P = 0.047), Rl till 1. AE .30 Pa/(mL/s) (P = 0.32). In 4 subjects the nasal provocation with cold air led to the sudden obstruction of nasal breathing and the absence of airflow during 30 minutes. A significant drop of FEV 1 after nasal provocation with cold air was registered in 4 out of 18 subjects. On average in the group the change of FEV 1 was -4. AE .1%.
Conclusion:
An acute nasal provocation with cold air leads to the increase of the nasal resistance in asthmatics with CAH and in each fifth patient to significant drop of FEV 1 . 
